Who owns the SYNDACCESS trademark?

The SYNDACCESS trademark is owned by Syndax Pharmaceuticals, Inc..

What is the serial number for SYNDACCESS?

The USPTO serial number for SYNDACCESS is 98423868.

What is the registration number for SYNDACCESS?

SYNDACCESS is registered under USPTO registration number 8393363.

SYN

USPTO Trademark Record

REGISTERED

SYNDACCESS

Q: What class is the SYNDACCESS trademark registered in?

The SYNDACCESS trademark is registered in Class 036 (Insurance, financial & real estate services), Class 044 (Medical, veterinary & beauty care services), Class 045 (Legal, security & personal social services).

SN 98423868·Reg 8393363·Filed Feb 27, 2024

Owner Syndax Pharmaceuticals, Inc.

Financial, monetary and banking services; insurance services; real estate services.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.; Legal services; security services for the physical protection of tangible property and individuals; dating services, online social networking services; funerary services; babysitting.

SYNDACCESS (Serial No. 98423868), Registration No. 8393363, is a registered US trademark filed on Feb 27, 2024 by Syndax Pharmaceuticals, Inc.. This trademark covers Class 036 (Insurance, financial & real estate services), Class 044 (Medical, veterinary & beauty care services), Class 045 (Legal, security & personal social services).

early section 8: August 11, 2032

Mark Intelligence

SYNDACCESS (Reg. #8393363) is a registered US trademark that has been protecting its owner, Syndax Pharmaceuticals, Inc., since 2024. The mark covers Class 036 (Insurance, financial & real estate services), Class 044 (Medical, veterinary & beauty care services) and Class 045 (Legal, security & personal social services) respectively. Goods and services include Financial, monetary and banking services; insurance services; real estate services.; Medical services; veterinary servic.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 27, 2024

SERIAL

98423868

REG#

8393363

REGISTERED

Aug 11, 2026

Owner

Applicant

Syndax Pharmaceuticals, Inc.

Entity

Corporation

State

Address

35 Gatehouse Drive, Building D, Floor 3, Waltham, MA, 02451

Country

Attorney

NameMark A. Jansen

Law firm

Mark A. Jansen Fenwick & West LLP

Docket

43707-00070

Address

801 California Street, Silicon Valley Center, Mountain View, CA 94041, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 27, 2024

Serial Number98423868

Registration No.8393363

Registration DateAug 11, 2026

Status DateAug 11, 2026

Published for OppositionJan 14, 2025

Mark TypeStandard characters

Attorney Docket43707-00070

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 036Insurance, financial & real estate services

US codes: 100, 101, 102

First use anywhere: Oct 31, 2024

First use in commerce: Oct 31, 2024

Financial, monetary and banking services; insurance services; real estate services.

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Oct 31, 2024

First use in commerce: Oct 31, 2024

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

Class 045Legal, security & personal social services

US codes: 100, 101

First use anywhere: Oct 31, 2024

First use in commerce: Oct 31, 2024

Legal services; security services for the physical protection of tangible property and individuals; dating services, online social networking services; funerary services; babysitting.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

41 events

REGISTERED-PRINCIPAL REGISTER

Aug 11, 2026

REGISTERED-PRINCIPAL REGISTER

SU-EXAMINER'S AMENDMENT WRITTEN

Jul 17, 2026

SU-EXAMINER'S AMENDMENT WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 17, 2026

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 17, 2026

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 17, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 17, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 17, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Apr 02, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Apr 02, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 02, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Mar 19, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 18, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Sep 10, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 10, 2025

USE AMENDMENT FILED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

May 21, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

WITHDRAWAL OF ATTORNEY GRANTED

May 21, 2025

WITHDRAWAL OF ATTORNEY GRANTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 19, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 19, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 19, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 14, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jan 14, 2025

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 08, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Dec 16, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 16, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 16, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 16, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 16, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Nov 14, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 14, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 14, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 14, 2024

EXAMINER'S AMENDMENT ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 22, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 22, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 22, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 18, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 18, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 18, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 16, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 08, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 27, 2024

NEW APPLICATION ENTERED

SYNDACCESS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Syndax Pharmaceuticals, Inc.

Other Marks by Mark A. Jansen

Resources

Company